Genmab | GEN - Créances Commerciales





Créances Commerciales Changement Date
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Almirall EUR 196.15M 20.22M 2026-06
Amarin USD 126.83M 477K 2025-12
Amgen USD 10.23B 1.09B 2026-06
argenx SE USD 2.01B 352.94M 2026-06
AstraZeneca USD 18.86B 972M 2026-06
Bayer EUR 18.7B 146M 2026-06
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Demant DKK 5.93B 426M 2026-06
Exelixis USD 322.21M 6.73M 2026-06
Fresenius Medical Care EUR 3.47B 250.22M 2026-06
Genmab DKK 1.22B 192M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
GN Store Nord DKK 2.44B 2.86B 2026-03
GRIFOLS EUR 1.19B 231M 2026-06
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Insmed USD 215.32M 36.77M 2026-06
Lakefront Biotherapeutics EUR 149.47M 95.44M 2026-06
Lonza CHF 1.78B 55M 2025-12
Merck EUR 4.95B 139M 2026-06
Novartis USD 9.85B 252M 2026-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sanofi EUR 492M 10M 2026-06
UCB EUR 1.97B 54M 2025-12